XERF vs Endolift: What Is the Difference and Which Is Right for You?
Oct 02, 2026
XERF vs Endolift: What Is the Difference and Which Is Right for You?
XERF and Endolift are different energy based technologies that may be used to improve selected degrees of facial laxity and contour in appropriately selected patients.
Their methods of delivering energy, however, are fundamentally different.
XERF is a non-invasive monopolar radiofrequency treatment. Energy is delivered from the skin surface without needles or skin incisions.
Endolift is a minimally invasive procedure in which a very fine laser fiber is introduced beneath the skin to deliver 1470 nm laser energy directly within the tissues.
The more useful question is therefore not which device is stronger, but what anatomical problem is present, which tissue level requires treatment and which procedure is most appropriate for that problem.
How does XERF work?
XERF uses two monopolar RF frequencies, 6.78 MHz and 2 MHz.
Electrical energy travels through the tissues and is converted into heat as it encounters tissue impedance.
Controlled heating is intended to produce collagen related changes and gradual tissue remodeling.
No needles or subdermal fibers are required.
How does Endolift work?
Endolift uses very fine optical fibers introduced beneath the skin.
These fibers deliver 1470 nm diode laser energy directly within the tissue plane selected by the physician.
The resulting photothermal effect is intended to produce tissue and collagen remodeling.
In appropriately selected cases, Endolift may also be used to influence limited deposits of localized fat.
What is the main difference between XERF and Endolift?
The most important difference is how energy reaches the tissue.
XERF delivers RF energy externally without penetrating the skin.
Endolift places a laser fiber beneath the skin, allowing laser energy to be delivered directly within the treated subdermal plane.
Endolift is therefore minimally invasive, while XERF is non-invasive.
Which is better for skin tightening?
There is currently no high quality direct clinical trial comparing XERF with Endolift and demonstrating that one produces greater tightening than the other.
XERF specific evidence is relatively new but early human studies have reported improvement in facial laxity.
Endolift has a larger published literature, including systematic reviews, although the quality of that evidence is variable.
A 2024 systematic review reported promising findings, while a separate 2025 systematic review raised concerns regarding high risk of bias, inconsistent treatment parameters and insufficient high quality evidence.
Current evidence therefore does not justify declaring a universal winner.
When might XERF be more suitable?
XERF may be considered when the goal is to improve selected degrees of tissue laxity using a non-invasive treatment without inserting an instrument beneath the skin.
It may also appeal to patients who prioritize limited recovery and prefer to avoid a minimally invasive procedure.
This does not mean it can correct every degree of facial laxity.
When might Endolift be more suitable?
Endolift may be considered when the physician wants to treat directly within the subdermal tissue plane, particularly when a selected patient has a combination of tissue laxity and limited localized fat.
Placement of the fiber within the tissues gives Endolift a different mechanism from externally delivered RF.
Being more invasive, however, does not automatically make it more effective for every patient.
Which is better for a double chin and submental fat?
The cause of submental fullness should be identified first.
Fullness may result from fat, skin laxity, limited chin projection, muscle anatomy, gland position or skeletal structure.
Endolift has published evidence suggesting an effect on selected localized fat deposits.
XERF should not currently be presented simply as a facial fat melting device.
Preclinical dual-frequency RF research demonstrates thermal distribution into subcutaneous tissue, but thermal exposure does not automatically establish fat cell destruction.
When substantial fat is the primary concern, neither technology should automatically be assumed to replace a procedure specifically designed for fat removal.
Which is more suitable for a thin face?
Preserving appropriate facial volume is particularly important in thin patients.
Current XERF evidence does not support describing the technology as primarily designed to destroy facial fat.
With Endolift, localized fat effects may be intentionally incorporated into treatment, so tissue plane and energy selection require particular care in patients who already have limited facial volume.
In a thin face, the objective may be improved firmness while preserving beneficial volume.
Which treatment requires anesthesia?
XERF does not use needles or a subdermal fiber, and a recent prospective clinical study was performed without topical anesthesia.
Endolift involves insertion of a fiber beneath the skin and therefore generally requires appropriate anesthesia according to treatment area and medical protocol.
The patient experience is consequently different between the two procedures.
Which has less downtime?
XERF is non-invasive and recovery is generally limited.
Temporary redness, swelling or sensitivity may occur.
Endolift is minimally invasive and can produce swelling, bruising, tenderness, tightness and temporary sensory changes.
XERF may therefore be more appropriate when minimal downtime is a major priority.
Individual recovery still varies.
Which produces faster results?
Both procedures may produce some early visible change, while a meaningful component of the result depends on gradual collagen and tissue remodeling.
Early swelling can also influence the appearance after Endolift.
XERF clinical studies have demonstrated continued change through three months of follow up.
Neither procedure should therefore be compared solely using immediately post treatment photographs.
Which requires more sessions?
There is no universal answer.
Current XERF studies have used one treatment in one study and two treatments in another.
Endolift may be performed as a single initial procedure in selected patients followed by reassessment after healing and remodeling.
Evidence does not currently establish one universal session number for either technology.
What about risks?
XERF is a non-invasive thermal treatment. Potential risks of inappropriate energy delivery include thermal injury, burns and unwanted skin changes, although early clinical studies have generally reported favorable tolerability.
Endolift involves placement of a fiber beneath the skin and therefore adds potential risks associated with subdermal treatment, including bruising, swelling, sensory changes, contour irregularities, thermal injury and uncommon injury to nearby structures.
Practitioner expertise, anatomical knowledge and appropriate treatment parameters matter with both technologies.
Can either treatment replace a surgical facelift?
No.
Neither XERF nor Endolift reproduces surgical removal of excess skin or repositioning of significantly descended facial tissues.
When substantial excess skin or advanced tissue descent is present, surgery may provide a type and degree of correction that non-invasive and minimally invasive energy based procedures cannot reproduce.
Can XERF and Endolift be combined?
They could theoretically form different parts of a treatment strategy when each has a clear objective.
However, there is currently insufficient clinical evidence demonstrating that routinely combining XERF and Endolift produces superior outcomes compared with appropriately selecting one treatment.
More treatment should not be equated with better treatment.
What does the scientific evidence show?
XERF specific evidence remains relatively new.
Direct human studies have reported short term improvement in facial laxity, but patient numbers remain small and follow up is limited.
Endolift has a broader published literature.
A 2024 systematic review included 23 studies and described generally promising findings while calling for larger controlled trials.
A separate 2025 systematic review was substantially more cautious, identifying high risk of bias, inconsistent treatment parameters and insufficient high quality research.
Most importantly, there is currently no robust head-to-head trial directly comparing XERF with Endolift.
Any claim that one is scientifically proven to be universally superior would therefore go beyond the current evidence.
The bottom line
XERF and Endolift are not interchangeable treatments.
XERF delivers non-invasive monopolar RF from the skin surface and offers controlled thermal tissue remodeling with generally limited recovery.
Endolift delivers 1470 nm laser energy through a fine fiber beneath the skin, allowing direct treatment within the subdermal plane and, in selected cases, an effect on localized fat.
The choice should depend on anatomy, degree of laxity, presence or absence of localized fat, facial volume, acceptable recovery and realistic treatment objectives.
Diagnosis should determine the technology rather than allowing the technology to determine the diagnosis.
Frequently asked questions
Is XERF better than Endolift?
Current evidence does not include a high quality direct comparison demonstrating universal superiority of either treatment.
Which is better for submental fat?
Endolift has published evidence involving selected localized fat, while XERF should not currently be described as a dedicated fat destruction treatment. The cause of submental fullness should first be diagnosed.
Which has less downtime?
XERF is non-invasive and generally has more limited recovery, while Endolift is minimally invasive and may produce more noticeable swelling and bruising.
Can XERF and Endolift be performed together?
Multiple technologies may be included in an individualized plan when each has a clear purpose, but current evidence does not support routinely combining them for every patient.
This content is intended for medical education and general patient information and does not recommend one technology for every patient. Treatment selection requires individual assessment of anatomy, tissue characteristics and clinical goals.
